electroCore Strengthens Patent Portfolio with Issuance of Four New U.S. Patents
21.09.2022 - Four patents issued expanding claims related to delivery of nVNS and other therapies using mobile devicesROCKAWAY, N.J., Sept. 21, 2022 (GLOBE NEWSWIRE) - electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today ... Seite 1